Opinion: GHG debate needs debit-credit balance

May 17, 2023

The home plate in baseball is 17 inches wide.

I listened to a presentation by the University of Saskatchewan agricultural economist Richard Gray at the end of March. In his submission, he suggested there was an error in greenhouse gas emission accounting. Kevin Hursh mentioned this in his column on page 11 of the April 6 issue.

Gray hypothesized that the accounting does not account for the carbon dioxide withdrawn from the atmosphere, converted to energy, stored in a kernel of grain, and exported to a user. The farm does not get credit for that exported carbon.

Industry champions support his hypothesis. I hear words like “rewarded,” and that past practices should be in the reward mix and the United Nations’ Intergovernmental Panel on Climate Change coefficients are wrong.

But the IPCC protocols for reporting emissions do address this energy transport. The accounting for respiratory emissions is on a worldwide scale. Their protocol is slightly less than a one-to-one debit and credit.

Click here to see more...

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.